Compounded Semaglutide Fridge Storage: Stability & Safety

Unopened compounded semaglutide stored at 2–8°C (36–46°F) typically remains stable for approximately 30 days, though the exact duration depends on the specific compounding pharmacy's formulation, vial type, and storage conditions. Most licensed 503A compounding pharmacies provide stability data and expiration guidance specific to their preparation.

Proper storage directly impacts medication potency and safety. Understanding how long your compounded semaglutide remains viable helps you plan treatment initiation, manage refill timing, and avoid wastage—all critical factors when beginning a GLP-1 protocol under provider supervision.

Compounded Semaglutide Stability: What the Science Shows

Compounded semaglutide stability depends on the active pharmaceutical ingredient (API), sterile diluent, preservatives, and vial closure system used by the 503A pharmacy. Unlike branded semaglutide (Ozempic, Wegovy), which undergoes rigorous FDA stability testing, each compounded preparation has its own stability profile determined by the compounding pharmacist.

Research on semaglutide degradation indicates that temperature fluctuations, light exposure, and repeated needle punctures accelerate potency loss. Most 503A compounding pharmacies assign a beyond-use date (BUD) of 30 days refrigerated, but this can vary. Always check the specific stability documentation provided with your medication.

Refrigeration Requirements and Storage Conditions Compared

Proper refrigeration is non-negotiable for compounded semaglutide. Temperature consistency, protection from light, and avoiding freezing all contribute to maintaining the medication's integrity throughout its shelf life. The following table outlines key storage factors and their impact on stability.

Timeline for Starting Treatment After Receiving Your Medication

Once you receive your compounded semaglutide, confirm the beyond-use date (BUD) or expiration printed on the vial or provided in documentation. If you plan to start treatment immediately, stability is not a concern; if there will be a delay, ensure the medication is properly refrigerated and used within the assigned timeframe.

Many patients receive their compounded semaglutide and hold it for 1–2 weeks before beginning dosing. Check your stability window with your pharmacy; most 30-day BUDs provide sufficient time for this. Plan your first injection before the expiration date to avoid medication loss.

Safety Considerations and When to Discard Compounded Semaglutide

If your compounded semaglutide has exceeded its beyond-use date, shows visible cloudiness, discoloration, or particulates, or has been left unrefrigerated for more than 2 hours, discard it safely according to local medication disposal guidelines. Do not use expired or compromised medication, as potency cannot be guaranteed.

Before starting any compounded GLP-1 therapy, work with your healthcare provider to confirm your baseline metabolic markers—including fasting glucose, HbA1c, lipid profile, and kidney function—to establish safe dosing and monitor response. Proper storage ensures the medication you use is potent and safe.

How PlexusDx Supports a More Personalized Approach

Understanding your medication's stability window is part of precision treatment planning at PlexusDx. Biomarkers such as baseline fasting glucose, HbA1c, and metabolic rate may help your provider determine when starting compounded semaglutide is most appropriate for your goals, ensuring the medication maintains full potency when you begin.

The PlexusDx Precision Peptide Genetic Test may help provide context about your predisposition in GLP-1 receptor and metabolic pathways—variants such as GLP1R rs6923761 and FTO rs9939609. While genetic data does not predict exact medication response, it can support a more informed conversation with your provider about whether compounded semaglutide aligns with your physiology and treatment readiness.

Combining proper storage practices with baseline biomarker assessment and genetic insights creates a more personalized approach to GLP-1 therapy. When your provider knows both your medication's stability status and your individual metabolic and genetic profile, dosing decisions and timing can be more precise.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Do Genetics Affect How Long My Reproductive Years Will Last
• Medvi Semaglutide